Seeing Is Believing
 
    
                    LRMR is currently covered by 7 analysts with an average price target of $38.04. This is a potential upside of $34 (841.58%) from yesterday's end of day stock price of $4.04.
Larimar Therapeutics's activity chart (see below) currently has 55 price targets and 66 ratings on display. The stock rating distribution of LRMR is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 29.41% with an average time for these price targets to be met of 242.41 days.
Highest price target for LRMR is $21, Lowest price target is $7, average price target is $13.8.
Most recent stock forecast was given by ANDREAS ARGYRIDES from OPPENHEIMER on 01-Oct-2025. First documented stock forecast 19-Mar-2015.
Currently out of the existing stock ratings of LRMR, 17 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$21
$16.79 (398.81%)
$26
29 days ago
(01-Oct-2025)
0/2 (0%)
$16.72 (390.65%)
Buy
$7
$2.79 (66.27%)
$10
1 months 1 days ago
(29-Sep-2025)
0/4 (0%)
$3.77 (116.72%)
Buy
$11
$6.79 (161.28%)
1 months 1 days ago
(29-Sep-2025)
0/2 (0%)
$7.77 (240.56%)
Buy
$18
$13.79 (327.55%)
$18
2 months 12 days ago
(18-Aug-2025)
1/12 (8.33%)
$14.35 (393.15%)
728
Buy
4 months 6 days ago
(24-Jun-2025)
2/4 (50%)
$17.17 (219.28%)
411
What is LRMR (Larimar Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on LRMR (Larimar Therapeutics) with a proven track record?
Which analyst has the most public recommendations on LRMR (Larimar Therapeutics)?
Which analyst is the currently most bullish on LRMR (Larimar Therapeutics)?
Which analyst is the currently most reserved on LRMR (Larimar Therapeutics)?